Joseph C Papa bought $350K of Emergent BioSolutions (EBS)

Executed May 13 2025, disclosed May 15 2025, 2 days later.

Value, as filed

$350K

60,000 sh × $5.83

Executed

May 13 2025

the trade date, as filed

Disclosed

May 15 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

+11.4%

+12.7% from execution

Over the 21 trading sessions from the disclosed entry session (May 15 2025), the stock returned +11.4% (delay-adjusted); from the execution session (May 13 2025), +12.7%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

JP Joseph C Papa President and CEO profile →

Joseph C Papa (President and CEO) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in EBS. Across 1 priced purchase filing, the average 21-session return was +12.7% from execution and +11.4% from disclosure (delay-adjusted; derived). The largest single filing was $350K of EBS (60,000 sh × $5.83, as filed), executed May 13 2025.

The name

EBS EBS EBS · 12 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→